Share Based Awards
The 2019 Equity Incentive Plan (the “2019 Plan”) and the 2024 Omnibus Equity Incentive Plan (the “2024 Plan”) (collectively, the “Plans”) allow us to incentivize key employees, consultants, and directors with long term compensation awards such as stock options, restricted stock, and restricted stock units (collectively, the “Awards”). The number of shares issuable in connection with Awards under the 2019 Plan were not to exceed 11,750,000. However, no shares are issuable under the 2019 Plan after the 2024 Plan became effective on October 15, 2024. The number of shares issuable in connection with Awards under the 2024 Plan may not exceed 24,603,000 plus any underlying forfeited 2019 Plan awards.
Options
The range of assumptions used to calculate the fair value of options granted was as follows:
Year ended
December 31, 2025
Eight months ended
December 31, 2024
Year ended
April 30, 2024
Exercise Price
$6.73 – $11.38
$1.15 – 4.02
$0.72 – 1.12
Stock price on date of grant
6.73 – 11.38
1.20 – 4.02
0.70 – 1.12
Risk-free interest rate
3.69% – 4.44%
3.54% – 4.44%
3.46% – 4.41%
Dividend yield
Expected term (years)
5.00 – 6.00
5.17 – 5.78
5.28 – 8.25
Volatility
135.54% – 191.15%
190.46% – 199.03%
206.99% – 262.07%

A summary of options activity under the Plan since April 30, 2023 was:
Shares
(in thousands)
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(in thousands)
Outstanding as of April 30, 20234,785$1.88 8.7275 
Granted2,9031.02 
Exercised(3)0.89 
Forfeited or expired(905)2.27 
Outstanding as of April 30, 20246,7801.46 8.022,762 
Granted1,4632.14 
Exercised(2,475)1.69 
Forfeited or expired(123)1.45 
Outstanding as of December 31, 20245,6451.54 7.9059,780 
Granted2,0517.58 
Exercised(2,723)1.29 
Forfeited or expired(272)2.41 
Outstanding as of December 31, 20254,7014.14 8.0418,616 
Exercisable as of December 31, 20251,085$1.63 5.52$6,865 
The aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price of each option. As of December 31, 2025, December 31, 2024 and April 30, 2024, there was $12.8 million, $4.1 million and $0.9 million of unrecognized stock-based compensation expense related to unvested stock options which is expected to be recognized over the weighted average periods of 1.46, 1.25 and 1.95 years, respectively.
Restricted Stock
A summary of restricted stock activity under the Plan since April 30, 2023 was:
Shares
(in thousands)
Weighted Average Grant-Date Fair Value Per
Share
Unvested and outstanding as of April 30, 2023781 $2.44 
Granted299 1.06 
Vested(485)1.92 
Forfeited(420)2.09 
Unvested and outstanding as of April 30, 2024175 2.09 
Granted3,073 2.58 
Vested(1,404)1.43 
Forfeited(300)1.14 
Unvested and outstanding as of December 31, 20241,544 $3.84 
Granted1,279 7.11 
Vested(352)7.19 
Forfeited(347)1.34 
Unvested and outstanding as of December 31, 20252,124 $5.67 
As of December 31, 2025, December 31, 2024 and April 30, 2024, there was $9.3 million, $5.3 million and $2.7 million of unrecognized stock-based compensation expense related to unvested restricted stock units which is expected to be recognized over the weighted average periods of 1.45, 1.25 and 0.26 years, respectively.
Stock Compensation
Stock compensation expense by functional operating expense was (in thousands):
Year ended
December 31, 2025
Eight months ended
December 31, 2024
Year ended
April 30, 2024
Research and development$1,152 $240 $395 
Sales and marketing2,319 1,040 562 
General and administrative7,091 2,823 2,652 
Total$10,562 $4,103 $3,609 
Stock compensation expense pertaining to options totaled $5.9 million, $1.2 million, and $2.6 million for the year ended December 31, 2025, for the eight months ended December 31, 2024, and for the year ended April 30, 2024, respectively. Stock compensation expense pertaining to restricted stock totaled $4.7 million, $2.9 million, and $1.0 million for the year ended December 31, 2025, for the eight months ended December 31, 2024, and for the year ended April 30, 2024, respectively

Historical Timeline

Fiscal YearFiled
2025Mar 19, 2026Showing above
2024Aug 8, 2024
2023Jul 27, 2023
2022Jul 27, 2022

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.